Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,217
Ph III recruiting: 128
Growth YoY: +13.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (886)

clinicaltrialsPublishedShowing 701–750 of 1,534 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05733598	Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	recruiting	Phase 2	60	Replimune, Inc.INDUSTRY	1	Apr 2, 2026	clinicaltrials
NCT06451497	This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors	recruiting	Phase 1	100	Zumutor Biologics Inc.INDUSTRY	1	Apr 2, 2026	clinicaltrials